116
Participants
Start Date
December 31, 2003
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Clofarabine 40mg/m^2
40 mg/m\^2 by vein over 1 hour daily for 5 days.
Idarubicin 10mg/m^2
"10 mg/m\^2 by vein over 30 minutes, around one hour after clofarabine, for the first 3 days of 5 day cycle.~Clofarabine + Idarubicin plus Ara-C:~6 mg/m\^2 by vein over 30 minutes, around one hour after clofarabine, for the first 3 days of 5 day cycle."
Ara-C 0.75 g/m^2
0.75 g/m\^2 by vein over 2 hours for 5 days in a row, on Days 1 to 5 of each cycle.
Clofarabine 22.5mg/m^2
22.5 mg/m\^2 by vein over 1 hour daily for 5 days.
Ara-C 1 g/m^2
1 g/m\^2 by vein over 2 hours for 5 days in a row, on Days 1 to 5 of each cycle.
Idarubicin 6 mg/m^2
6 mg/m\^2 by vein over 30 minutes, around one hour after clofarabine, for the first 3 days of 5 day cycle.
UT MD Anderson Cancer Center, Houston
Genzyme, a Sanofi Company
INDUSTRY
M.D. Anderson Cancer Center
OTHER